Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Y Dirix

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of the National Cancer Institute|June 20, 2018
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) TrialAntonia K Roseweir, Lindsay Bennett, Ashley Dickson, et al.
The Journal of Molecular Diagnostics : JMD|October 9, 2018
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNASilvia R Vitale, Anieta M Sieuwerts, Nick Beije, et al.
Breast (Edinburgh, Scotland)|March 10, 2015
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized studyVéronique Diéras, Hans Wildiers, Jacek Jassem, et al.
Molecular Oncology|October 25, 2017
Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patientsNick Beije, Anieta M Sieuwerts, Jaco Kraan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2012
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysisWillemien van de Water, Duveken B Y Fontein, Johanna G H van Nes, et al.
Molecular Oncology|June 11, 2019
AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxelAnieta M Sieuwerts, Wendy Onstenk, Jaco Kraan, et al.
European Urology|July 20, 2015
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor CellsWendy Onstenk, Anieta M Sieuwerts, Jaco Kraan, et al.
Journal of the National Cancer Institute|January 9, 2014
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancerNing Qing Liu, Christoph Stingl, Maxime P Look, et al.
The Journal of Molecular Diagnostics : JMD|February 24, 2018
An In-Depth Evaluation of the Validity and Logistics Surrounding the Testing of AR-V7 mRNA Expression in Circulating Tumor CellsAnieta M Sieuwerts, Bianca Mostert, Michelle van der Vlugt-Daane, et al.
BMC Cancer|February 20, 2016
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patientsEsther A Reijm, Anieta M Sieuwerts, Marcel Smid, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|June 20, 2018
Predictive Biomarkers for Endocrine Therapy: Retrospective Study in Tamoxifen and Exemestane Adjuvant Multinational (TEAM) TrialAntonia K Roseweir, Lindsay Bennett, Ashley Dickson, et al.
The Journal of Molecular Diagnostics : JMD|October 9, 2018
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNASilvia R Vitale, Anieta M Sieuwerts, Nick Beije, et al.
Breast (Edinburgh, Scotland)|March 10, 2015
Trebananib (AMG 386) plus weekly paclitaxel with or without bevacizumab as first-line therapy for HER2-negative locally recurrent or metastatic breast cancer: A phase 2 randomized studyVéronique Diéras, Hans Wildiers, Jacek Jassem, et al.
Molecular Oncology|October 25, 2017
Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patientsNick Beije, Anieta M Sieuwerts, Jaco Kraan, et al.
European Journal of Cancer (Oxford, England : 1990)|September 8, 2012
Influence of semi-quantitative oestrogen receptor expression on adjuvant endocrine therapy efficacy in ductal and lobular breast cancer - a TEAM study analysisWillemien van de Water, Duveken B Y Fontein, Johanna G H van Nes, et al.
Molecular Oncology|June 11, 2019
AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxelAnieta M Sieuwerts, Wendy Onstenk, Jaco Kraan, et al.
European Urology|July 20, 2015
Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor CellsWendy Onstenk, Anieta M Sieuwerts, Jaco Kraan, et al.
Journal of the National Cancer Institute|January 9, 2014
Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancerNing Qing Liu, Christoph Stingl, Maxime P Look, et al.
The Journal of Molecular Diagnostics : JMD|February 24, 2018
An In-Depth Evaluation of the Validity and Logistics Surrounding the Testing of AR-V7 mRNA Expression in Circulating Tumor CellsAnieta M Sieuwerts, Bianca Mostert, Michelle van der Vlugt-Daane, et al.
BMC Cancer|February 20, 2016
An 8-gene mRNA expression profile in circulating tumor cells predicts response to aromatase inhibitors in metastatic breast cancer patientsEsther A Reijm, Anieta M Sieuwerts, Marcel Smid, et al.
Pageof 9